| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-10 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.21 | 9e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |